Goos

Category

Growth Hormone Research Peptides

Growth-hormone secretagogues and releasing peptides for GH-axis research applications.

Growth Hormone Research Peptides

CJC-1295 DAC

CND5

CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.

Formula
C₆₂H₉₈N₁₆O₂₂
MW
1419.56 g/mol
Purity
99% HPLC
Length
15 aa

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that can increase the levels of growth hormone and insulin-like growth factor-1 (IGF-1) in plasma.

View Details
Growth Hormone Research Peptides

CJC-1295 no DAC

Modified Growth Hormone-Releasing Factor (1-29)。

CJC-1295 (no DAC) (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.

Formula
C₁₅₂H₂₅₂N₄₄O₄₂
MW
3367.94 g/mol
Purity
99% HPLC
Length
29 aa

Research on growth hormone release and signaling pathways involving GH and IGF-1.

View Details
Growth Hormone Research Peptides

Tesamorelin

Tesamorelin, is a syntheitic peptide consiting of 44 amino acids. It is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional, toxic fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction visceral fat. This peptide has been found to reduce adiposity by nearly 20% in this population [1]. Research suggests that tesamorelin is approximately 4 times more effective in reducing adiposity than all of the other available therapies combined [2].

Formula
—
MW
5195.91 g/mol
Purity
99% HPLC
Length
44 aa
View Details

Looking for a Specific Peptide?

Contact our team for product information, specifications, documentation, and availability.